- Home
- LAW vs HRTX Comparison
LAW vs HRTX Comparison
Compare LAW & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LAW | HRTX |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 274.2M | 228.3M |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | LAW | HRTX |
|---|---|---|
| Price | $3.97 | $0.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $8.00 | $4.50 |
| AVG Volume (30 Days) | 520.2K | ★ 2.2M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $156,849,000.00 | $154,904,000.00 |
| Revenue This Year | $11.23 | $15.28 |
| Revenue Next Year | $10.60 | $20.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.29 | 7.36 |
| 52 Week Low | $2.45 | $0.74 |
| 52 Week High | $9.11 | $2.30 |
Technical Indicators
Market Signals| Indicator | LAW | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.85 | 40.49 |
| Support Level | $3.81 | $0.83 |
| Resistance Level | $5.03 | $1.34 |
| Average True Range (ATR) | 0.26 | 0.06 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 73.96 | 16.15 |
Price Performance
Historical ComparisonAbout LAW CS Disco Inc.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.